The
global Medical Writing
Market size
is expected to reach USD 6.9 billion by 2026 registering a CAGR of around 10%,
according to a new report by Grand View Research, Inc. Increasing demand for
regulatory paperwork in the pharmaceutical and biotechnology industries is
driving the medical writing market. Rising need for marketable written content
to convey drug-related information to healthcare professionals and patients is
also likely to augment the market growth. Pharmaceutical companies face many
regulatory complexities, this creates a need for expertise in different
portfolios driving the demand for clinical services outsourcing market.
Increasing
R&D costs are expected to drive this demand further over the forecast
years. Drug manufacturers outsource the production of medicines in the form of
clinical trials. Large-scale pharma organizations have in-house medical writing
division. However, rise in patent expiry in recent years has resulted in a
compelling need to gain efficiencies and reduce costs. A survey by CenterWatch
on pharmaceutical services reported that medical writing is the fourth most
outsourced clinical function. Majority of such services are outsourced by drug
manufacturers to the developed regions.
However,
developing countries, such as China and India, have been able to capture a
share in this industry due to the availability of the labor force. Low costs,
along with a high number of science graduates, gives developing economies an
advantage over other regions. North America was the dominant regional market in
2018 due to a comprehensive regulatory framework for novel drug and healthcare
products. Asia Pacific is expected to be the fastest-growing market owing to
availability of the labor force and increasing number of CROs.
Browse
Details of Report @
https://www.grandviewresearch.com/industry-analysis/medical-writing-market
https://www.grandviewresearch.com/industry-analysis/medical-writing-market
Further key
findings from the study suggest:
- The clinical writing type segment led
the global medical writing market , in terms of revenue, in 2018 and is
projected to maintain its dominance over the forecast period
- Regulatory writing is expected to
witness the fastest CAGR from 2019 to 2026 due to need for regulatory
documents for submission in support of approval or maintenance of
healthcare products
- Medical journalism led the application
segment in the past due to increasing need for multiple reliable sources
of medical information and update on current treatment methodologies in
the drug industry
- CROs held the majority share of the end
use segment in 2018 on account of rapid expansion of CROs in developing
economies and increasing cost of drug development
- IQVIA; PAREXEL International Corp.;
Trilogy Writing & Consulting GmBH; Covance, Inc.; OMICS International;
and Freyr Solutions are some of the key companies in the global market
About
Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment